February 21st 2023
Looking to the future, a panel of experts offer closing remarks on promising developments and unmet needs in the treatment of NSCLC.
February 14th 2023
Experts discuss the role of neoadjuvant therapy and other emerging therapies in the treatment of early-stage NSCLC.
Jaspal Singh, MD, MHS, shares insights on treatment strategies for patients with stage II-IIIA NSCLC.
February 7th 2023
David H. Harpole Jr, MD, presents a case of a former smoker diagnosed with NSCLC, and David Spigel, MD, offers his initial impressions.
An expert panel shares perspectives on how to choose the appropriate patients with non-small cell lung cancer for lung resection.
January 31st 2023
A panel of distinguished experts discuss how detection of actionable mutations affect their treatment choices in non-small cell lung cancer.
David Spigel, MD, and David H. Harpole Jr, MD, describe when adjuvant therapy is recommended in early stage NSCLC and discuss data from recent clinical trials of adjuvant therapy.
January 24th 2023
A panel of experts in the treatment of NSCLC discusses how they manage patients with stage IB disease.
David H. Harpole Jr, MD, a thoracic surgeon, details his workup approach and discussed molecular testing for patients who present with NSCLC.
January 17th 2023
David Spigel, MD, presents a patient case of a 57-year-old woman with NSCLC, and Jaspal Singh, MD, MHS, discusses his approach to initial evaluation.
A panel of experts introduce themselves and explain their approaches to multidisciplinary care in treating non-small cell lung cancer.